(Q43601443)

25 November 2017

title

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia (English)

1 reference

25 November 2017

0 references

0 references

Sumiyoshi T

1 reference

25 November 2017

Matsui M

1 reference

25 November 2017

Yamashita I

1 reference

25 November 2017

Nohara S

1 reference

25 November 2017

Kurachi M

1 reference

25 November 2017

Uehara T

1 reference

25 November 2017

Sumiyoshi S

1 reference

25 November 2017

Sumiyoshi C

1 reference

25 November 2017

Meltzer HY

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

published in

Biological Psychiatry

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

861-868

1 reference

5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

What are the functional consequences of neurocognitive deficits in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Nicotine-haloperidol interactions and cognitive performance in schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Relationships between verbal memory performance and the cerebral distribution of fluorodeoxyglucose in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Actions of 5-HT on human neocortical neurones in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

The cognitive efficacy of atypical antipsychotics in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

Interaction of SM-3997 with serotonin receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901025-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)01025-8

1 reference

25 November 2017

1 reference